home / stock / argx / argx articles

ARGX Articles, argenx SE - From 06/04/24

Stock Information
Company Name: argenx SE
Stock Symbol: ARGX
Market: NASDAQ
Website: argenx.com
Menu
ARGX ARGX Quote ARGX Short ARGX News ARGX Articles ARGX Message Board
Get ARGX Alerts

News, Short Squeeze, Breakout and More Instantly...
argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

June 4, 2024Amsterdam, the Netherlands – argenx ((Euronext &amp, NASDAQ:ARGX), a global immunology company committed to improving the lives...
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study | Benzinga

Biohaven Ltd’s (NYSE:BHVN) shares are trading lower on Wednesday. The company reported new interim data from the ongoing Phase 1 study of BHV...

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results. Duol...

Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of AppLovin Corporation (NASDAQ:APP) rose sharply in today's pre-market trading after the company reported better-than-expected first-q...
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session | Benzinga

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of Exact Sciences Corporation (NASDA...

argenx Reports First Quarter 2024 Financial Results and Provides Business Update | Benzinga

$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track t...

argenx announces results of Annual General Meeting of Shareholders | Benzinga

May 7, 2024 – 5:30pm ET Amsterdam, the Netherlands – argenx SE ((Euronext &amp, NASDAQ:ARGX), a global immunology company committed to im...
argenx to Present at BofA Securities 2024 Health Care Conference | Benzinga

May 7, 2024Amsterdam, the Netherlands – argenx ((Euronext &amp, NASDAQ:ARGX), a global immunology company committed to improving the lives ...

argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 | Benzinga

May 2, 2024Amsterdam, the Netherlands – argenx ((Euronext &amp, NASDAQ:ARGX), a global immunology company committed to improving the lives ...

argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease | Benzinga

ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patien...
Previous 10 Next 10